Less than a year ago, I sat down with the CEO of what used to be a $1 billion company. The company is well-known, does business with some of the world's largest travel and hospitality companies like Marriott International
"We have to invest year after year to maintain our competitive advantage."
"There's little that we do that no one else can do."
Are you kidding?
"We continually have to adjust for some kind of 'vaporization' effect with respect to our write-offs."
Out of journalistic considerations, I can't tell you the name of the stock. But the simple truth is that since the interview, shares have dropped more than 40% -- so people are definitely getting the picture.
Dime a dozen
You might even be able to find the stock if you looked hard enough -- actually, you could probably find dozens more in similar predicaments. While I thought the exec honorable for his candid truth-telling -- and that's a big plus in my book -- it's not good enough for any investment of mine. The point here is universal: If the person I interviewed sounds anything even remotely like the CEO of a company in your portfolio, dump that stock. Now.
A lasting competitive advantage is a vital element of a great business. Without it, a company's brief edge in sales or technology will disintegrate like a finely built sandcastle on the beach.
Remember when IBM was the only company mass-producing individual computers? It was making money hand over fist -- and yet it couldn't maintain that momentum. Eventually others like Dell
A deadly trap
No matter how good a product or a service is, if it can be replicated by others, it's not worth much. In time, competitors will squeeze margins, batter revenue growth, and produce a red ocean of competition. More and more each year will need to be invested, only to receive a smaller piece of the earnings pie in return.
That's precisely why Intuitive Surgical has delivered more than 1,500% gains in the past five years. No one is even close to replicating the company's technology or its products. And this explains why Boeing
Clearly, the whole mystery of large-scale flight isn't stumping too many engineers -- so the secret to success these days includes juicing margins as much as possible and seizing lucrative contracts. Instead, examine a business in the same industry that has built a competitive advantage through different means: it's Stock Advisor selection Embraer
Investing legends will tell you the same thing. Among others, Warren Buffett has made billions identifying companies that leverage products or brands whose edge was not in danger. UnitedHealth
Back to the horror story
I knew going into the CEO interview that I didn't really like the company's position in the industry. So when I got a sense that he was willing to talk, I pushed harder. I asked him whether the company had any kind of ringer in the pipeline -- perhaps a blockbuster project in one important segment that investors could look forward to. His response?
"There's no killer application."
Man. Sell that sucker.
Foolish bottom line
If you own shares of a company that has no real barriers to hungry competition, and it doesn't have anything in the works for the future, then what do you have? Not that much, really.
Instead, focus on the companies that do. Every single one of the recommendations in Motley Fool Stock Advisor leverages some kind of competitive advantage -- it's a crucial aspect of our selection process. And the strategy has paid off: We're currently beating the market by nearly 42 percentage points since inception in 2002. Want to take a look? Try the service free for 30 days.
Fool analyst Nick Kapur owns no shares of any company mentioned above and has zero material interest in the company whose CEO he interviewed -- although he wishes he could tell you the name of it. Intuitive Surgical is a Motley Fool Rule Breakers recommendation. Embraer, United Health, and Apple are Stock Advisor picks. Dell and UnitedHealth are Inside Value selections. The Fool has a disclosure policy.
More from The Motley Fool
GM Proved Doubters Wrong in 2017 With a Strong Crossover Lineup
GM surprised the market when it announced strong guidance thanks to a revamped line of crossovers and SUVs. Better still, it delivered on the promises.
Ford's Behind-the-Scenes Focus on Data
Ford’s recent partnerships and small-scale tests could bode well for the future.
Ford's Tumultuous 2017
Ford’s stock languished behind GM throughout 2017. Will 2018 be a turnaround year?